Table 2. Factors associated with HCV testing: logit mixed model, univariable and multivariable analyses, ANRS-AERLI study (n = 202 individuals, N = 395 observations).
Univariable analyses | Multivariable analysis | |||
---|---|---|---|---|
OR [95%CI] | p-value | aOR [95%CI] | p-value | |
Gender | ||||
male | 1 | |||
female | 0.55 [0.20; 1.47] | 0.23 | ||
Age§ | 1.03 [0.97; 1.09] | 0.37 | ||
Education | ||||
< High School Certificate | 1 | |||
≥ High School Certificate | 0.84 [0.33; 2.12] | 0.71 | ||
Living in a couple | ||||
No | 1 | |||
Yes | 1.37 [0.62; 3.03] | 0.44 | ||
Age at first drug injection§ | 0.99 [0.92; 1.06] | 0.77 | ||
Stable housing | ||||
No | 1 | |||
Yes | 0.58 [0.26; 1.28] | 0.18 | ||
Paid activity | ||||
No | 1 | |||
Yes | 1.24 [0.59; 2.60] | 0.58 | ||
Age at first regular drug use | 0.97 [0.91; 1.04] | 0.47 | ||
Currently on OMT | ||||
No | 1 | |||
Yes | 1.84 [0.80; 4.22] | 0.15 | ||
Polydrug use | ||||
No | 1 | |||
Yes | 0.91 [0.38; 2.17] | 0.84 | ||
Harmful alcohol consumption ⱡ | ||||
No | 1 | |||
Yes | 0.72 [0.34; 1.54] | 0.40 | ||
Heroin use* | ||||
No | 1 | |||
Yes | 0.83 [0.39; 1.78] | 0.63 | ||
Cocaine use* | ||||
No | 1 | |||
Yes | 1.48 [0.71; 3.11] | 0.30 | ||
Crack use* | ||||
No | 1 | 1 | ||
Yes | 0.13 [0.02; 0.84] | 0.03 | 0.11 [0.02; 0.80] | 0.030 |
Morphine sulfate use* | ||||
No | 1 | |||
Yes | 0.73 [0.34; 1.56] | 0.42 | ||
Buprenorphine use* | ||||
No | 1 | 1 | ||
Yes | 2.53 [1.07; 5.98] | 0.04 | 2.85 [1.08; 7.53] | 0.034 |
Daily frequent injection** | ||||
No | 1 | |||
Yes | 1.45 [0.71; 2.95] | 0.31 | ||
Intervention group | ||||
No | 1 | 1 | ||
Yes | 0.85 [0.38; 1.90] | 0.69 | 0.72 [0.24; 2.13] | 0.547 |
Follow-up time | ||||
M0 | 1 | 1 | ||
M6 or M12 | 1.13 [0.61; 2.12] | 0.69 | 0.67 [0.28; 1.59] | 0.362 |
Interaction | ||||
Intervention group at M0 | 1 | |||
Intervention group at M6 or M12 | 4.13 [1.03; 16.60] | 0.046 |
§in years
ⱡ AUDIT-C ≥ 3 for women and ≥4 for men
*during the previous 4 weeks
** more than 3 times a day; (a) OR = (adjusted) odds-ratio; CI = confidence interval.